Ads
related to: hypertrophic cardiomyopathy- Watch A Video
See What Your Peers Are Saying
About This Treatment Option.
- HCP Treatment Information
Learn About a Treatment Option for
Patients with CV Disease.
- Connect With A Rep
Connect With A Representative For
Resources or Support.
- Real Patient Stories
Watch Patients Talk About Their
LDL-C & Experience with ASCVD.
- Resources for Patients
Get Helpful and Downloadable
Resources to Support Your Practice.
- Review Patient Profiles
Identify Patients Who Are At
Risk of Another CV Event.
- Watch A Video
Search results
Hypertrophic Cardiomyopathy Guidelines Add Drug Class, Endorse More Exercise
MedPage Today· 3 days agoUpdates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse...
Exercise, new drug class recommended for management of hypertrophic cardiomyopathy
Medical Xpress· 3 days agoThe American College of Cardiology (ACC) and the American Heart Association (AHA) have released a...
Is exercise safe for people with an inherited heart condition?
San Francisco Chronicle· 3 days agoOver the years, people with a genetic condition causing thickening of the heart muscle, known as hypertrophic cardiomyopathy, have received confusing advice ...
Benefit for Local 5’s Shaun Kornusky & family taking place Friday at Stadium View
WFRV Green Bay via Yahoo News· 3 days agoGREEN BAY, Wis. (WFRV)—Shaun Kornusky, an account executive on the sales team at WFRV, has ...
Brazilian Society of Cardiology Updates Three Guidelines
Medscape· 1 day agoThe Brazilian Society of Cardiology (SBC) has just updated its guidelines on hypertension and...
Edgewise Therapeutics doses first subject in HCM drug trial
Clinical Trials Arena via Yahoo Finance· 4 days agoUS-based biopharmaceutical company Edgewise Therapeutics has dosed the first subject in the Phase II...
Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
GuruFocus.com via Yahoo Finance· 17 hours agoAdditionally, Cytokinetics announced the initiation of CEDAR-HCM, a trial focusing on pediatric...
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.40
ETF DAILY NEWS· 8 hours agoTenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are covering the stock, Marketbeat.com reports. Canaccord Genuity ...
Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlig
Guru Focus· 3 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Cytokinetics Inc (CYTK, Financial) reported substantial progress in its muscle biology focused ...
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoCytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript May 9, 2024 Cytokinetics,...
